SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-005975
Filing Date
2020-01-22
Accepted
2020-01-22 17:06:03
Documents
1
Group Members
JAD FAKHRYPOPLAR POINT CAPITAL GP LLCPOPLAR POINT CAPITAL PARTNERS LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm205584d1_sc13ga.htm SC 13G/A 103096
  Complete submission text file 0001104659-20-005975.txt   105024
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 20539528
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 840 HINCKLEY ROAD, SUITE 250 BURLINGAME CA 94010
Business Address 840 HINCKLEY ROAD, SUITE 250 BURLINGAME CA 94010 650-239-9049
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001588273 (see all company filings)

IRS No.: 460530967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A